Teva Pharmaceuticals USA Recall: Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- coun
Teva Pharmaceuticals USA Recall: Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- coun is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Teva Pharmaceuticals USA; Product: Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals U
| Recalling firm | Teva Pharmaceuticals USA |
|---|---|
| Product | Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02 |
| Reason for recall | CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide. |
| Recall initiated | 20140124 |
| Recall number | D-1093-2014 |
| Category | drug |
| State | PA |
| Country | United States |
$29/mo
Try RecallGuard →